What is the most recent earnings date for CALT stock?
Calliditas Therapeutics AB (CALT) last reported earnings on 8/13/2024.
Calliditas Therapeutics AB (CALT) Earnings History & Surprises
NASDAQ:CALT • US13124Q1067
Current stock price
40.0001 USD
-0.16 (-0.4%)
Last:
CALT Earnings overview
Past quarterly earnings results for Calliditas Therapeutics AB (CALT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Nov 11, 2024
- Period
- Q3 / 2024
- EPS Estimate
- SEK2.49
- Revenue Estimate
- 547.4M
Last Reported
Most Recent- Release Date
- Aug 13, 2024
- Period
- Q2 / 2024
- EPS Reported
- -SEK1.75
- EPS Surprise
- -181.66%
- Revenue Surprise
- 22.03%
Beat Rate
Last 8 Quarters 50%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in SEK): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | -1.75 | -0.62 | -181.66% | 48.54% | 559.78M | 458.71M | 22.03% | 107.80% |
| Q1 2024 | -9.12 | -3.36 | -171.73% | -31.52% | 295.481M | 379.04M | -22.04% | 54.42% |
| Q4 2023 | -0.68 | -3.54 | 80.89% | -385.71% | 451.561M | 364.28M | 23.96% | 5.25% |
| Q3 2023 | -6.24 | -0.58 | -979.13% | -1,747.06% | 294.592M | 376.01M | -21.65% | 13.28% |
| Q2 2023 | -3.40 | -4.41 | 22.90% | 52.76% | 269.384M | 286.08M | -5.84% | 320.60% |
| Q1 2023 | -6.94 | -3.48 | -99.31% | - | 191.352M | 269M | -28.87% | 284.75% |
| Q4 2022 | -0.14 | -3.50 | 96.03% | 98.33% | 429.042M | 196.22M | 118.65% | 1,276.02% |
| Q3 2022 | -0.34 | -6.18 | 94.53% | - | 260.056M | 144.72M | 79.70% | 31.23% |
| Q2 2022 | -7.19 | -8.66 | 16.91% | - | 64.047M | 53.045M | 20.74% | - |
| Q1 2022 | - | - | 49.734M | - | - | |||
| Q4 2021 | -8.33 | -7.61 | -9.35% | -8.26% | 31.18M | - | 7,695.00% | |
| Q3 2021 | - | - | 198.167M | - | - | |||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | -100.00% | ||||
| Q4 2020 | -7.69 | - | - | 400K | 12.129M | -96.70% | - | |
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | 474K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-312.91%
Max EPS beat (4)
80.89%
Min EPS beat (4)
-979.13%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
0.57%
Max Revenue beat (4)
23.96%
Min Revenue beat (4)
-22.04%
Analysis
In the last 4 quarters, CALT has beaten EPS estimates in 1 out of 4 releases
CALT has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, CALT reported -312.9% below the EPS estimates on average.
In the last 4 quarters, CALT has beaten the revenue estimates by 0.6% on average.
Related analysis
Calliditas Therapeutics AB / CALT Earnings FAQ
Did Calliditas Therapeutics AB (CALT) beat earnings estimates last quarter?
Calliditas Therapeutics AB (CALT) missed EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does CALT stock beat earnings estimates?
In the last 4 quarters, Calliditas Therapeutics AB (CALT) has beaten EPS estimates in 1 out of 4 releases.